Conference icon

Conference

The thiopurine methyltransferase TPMT *1/*3A genotype is associated with a better treatment outcome in the UK ALL97 trial for childhood acute lymphoblastic leukaemia; TPMT heterozygosity is not associated with secondary cancers

Publication status:
Published

Actions


Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Clinical Trial Service Unit
Role:
Author
More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Clinical Trial Service Unit
Role:
Author
Expand authors...
Volume:
70
Issue:
2
Pages:
298-299
Publication date:
2010-08-05
ISSN:
0306-5251
URN:
uuid:c56b4cfe-ebb1-4efd-a512-d21e35a28eff
Source identifiers:
95972
Local pid:
pubs:95972

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP